Physician profile
Arthur Mandy
NPI 1508146531
$373.89
in general payments reported to CMS, 2019-2025
10 companies · $34.42 in 2025
The $34.42 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.05 · 2023: $178 · 2024: $145 · 2025: $34.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $178.43 | 2023 | Aquabeam Robotic System |
| Astrazeneca Pharmaceuticals Lp | $34.77 | 2024-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.40 | 2024-2025 | Jardiance |
| Abbott Laboratories | $23.11 | 2024 | Proclaim |
| Dexcom, INC. | $20.38 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $19.66 | 2024 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $19.28 | 2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $18.18 | 2024 | Trintellix |
| Currax Pharmaceuticals LLC | $16.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Mandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.